An Imaging-based Quantitative Biomarker Assay for NAFLD in Children (NCT06354491)

🧪 Interventions in This Study

• Magnetic Resonance Imaging (MRI) (DEVICE)
• Ultrasound (US) (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• University of Wisconsin, Madison — Madison, Wisconsin

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in NAFLD

• Accurate Point of Care Liver Disease Diagnostics — La Jolla, California
• Effect of VLCD on the Reduction of Liver Steatosis and Fibrosis in Subjects With Obesity and NAFLD — Iowa City, Iowa
• Nonalcoholic Fatty Liver Disease in HIV Database — Birmingham, Alabama
• LITMUS Imaging Study — San Antonio, Texas
• Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV — Tuscaloosa, Alabama

Explore by condition: All NAFLD clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.